IP Library Granted Patent US 7,592,466
Granted Patent B2
US 7,592,466 · App. 10/961,362 · Granted Sep 22, 2009

Ureas having antiangiogenic activity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,592,466
App. No.
10/961,362
Granted
Sep 22, 2009
Kind
B2
Abstract

Compounds having the formula are angiogenesis inhibitors. Also disclosed are compositions containing the compounds, methods of making the compounds, and methods of treatment using the compounds.

Claims (111)

1. A compound of formula (I)

or a therapeutically acceptable salt thereof, wherein

A is selected from the group consisting of pyridazinyl, pyridinyl, pyridine N-oxide, pyrimidinyl, indol-3-yl, pyrazol-4-yl, pyrazinyl, isoxazol-4-yl, and triazinyl;

R 1 and R 2 are independently selected from the group consisting of hydrogen, alkenyl, alkoxy, alkoxyalkyl, alkyl, alkynyl, aryl, arylalkyl, cyanoalkyl, cycloalkyl, (cycloalkyl)alkyl, haloalkyl, heterocyclyl, heterocyclylalkyl, hydroxyalkyl, (NR A R B )alkyl, and (NR A R B )carbonyl; or

R 1 and R 2 , together with the nitrogen atom to which they are attached, form a five- to seven-membered ring containing zero or one additional heteroatom selected from the group consisting of nitrogen, oxygen, and sulfur, wherein the remaining atoms are carbon; wherein the ring can be optionally substituted with one, two, three, or four substituents independently selected from the group consisting of alkoxy, alkoxyalkyl, alkoxycarbonyl, alkoxycarbonylalkyl, alkyl, alkylene, alkylcarbonyl, alkylsulfanylalkyl, aryl, arylalkyl, arylcarbonyl, arylcarbonylalkyl, cycloalkyl, (cycloalkyl)alkyl, (cycloalkyl)carbonyl, (cycloalkyl)carbonylalkyl, ethylenedioxy, haloalkoxy, haloalkyl, heterocyclyl, heterocyclylalkyl, heterocyclylcarbonyl, heterocyclylcarbonylalkyl, hydroxy, hydroxyalkyl, NR A R B , (NR A R B )alkyl, and (NR A R B )carbonyl;

R 3 at each occurance is independently selected from the group consisting of alkenyl, alkoxy, alkoxyalkyl, alkoxycarbonyl, alkyl, alkylcarbonyl, alkylsulfanyl, aryl, arylalkyl, aryloxy, cyano, cyanoalkyl, cycloalkyl, (cycloalkyl)alkyl, halo, haloalkyl, heterocycle, hydroxy, hydroxyalkyl, and nitro;

X is selected from the group consisting of O and S;

m is 0-4; and

R A and R B are independently selected from the group consisting of hydrogen, alkenyl, alkoxyalkyl, alkyl, alkynyl, alkylcarbonyl, aryl, arylalkyl, cycloalkyl, (cycloalkyl)alkyl, heterocyclyl, heterocyclylalkyl, and hydroxyalkyl.

2. The compound of claim 1 wherein A is pyridinyl.

3. The compound of claim 2 wherein R 3 is alkyl; X is O; and m is 1.

4. The compound of claim 3 wherein R 1 is selected from the group consisting of hydrogen and alkyl; and R 2 is heterocyclylalkyl.

5. A compound of claim 1 selected from the group consisting of

N-benzyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}-1-pyrrolidinecarboxamide;

N-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}-N′-[3-(4-morpholinyl)propyl]urea;

N-[2-(1H-imidazol-4-yl)ethyl]-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-[2-(1H-indol-3-yl)ethyl]-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-ethyl-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-isobutyl-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-(1-methylbutyl)-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}-N′-neopentylurea;

N-(3,3-dimethylbutyl)-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}-N′-(2,2,2-trifluoroethyl)urea;

N-(2-methoxy-1-methylethyl)-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-(2-ethoxyethyl)-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}-N′-(tetrahydro-3-furanylmethyl)urea;

N-(cyanomethyl)-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}-N′-2-propynylurea;

N-(cyclopropylmethyl)-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-cyclobutyl-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-cyclohexyl-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-(4-methylcyclohexyl)-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-(cyclohexylmethyl)-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-cycloheptyl-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-[(1S)-1-(hydroxymethyl)-3-methylbutyl]-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-[(1R)-1-(hydroxymethyl)-3-methylbutyl]-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-[(1S)-2-hydroxy-1-phenylethyl]-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-(3-isopropoxypropyl)-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-(2,3-dihydroxypropyl)-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}-N′-[2-(2-thienyl)ethyl]urea;

N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-(2,4-difluorobenzyl)-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-(3,3-diphenylpropyl)-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-[(1R)-2-hydroxy-1-phenylethyl]-N′-{(3R)-1-[(6-methyl-3-pyridinyl)carbonyl]-3-pyrrolidinyl}urea;

N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N′-[(1S)-1-phenylethyl]urea;

N,N-dibutyl-N′-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N′-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N-isopropyl-N-(2-methoxyethyl)urea;

N-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-1,3,3-trimethyl-6-azabicyclo[3.2.1]octane-6-carboxamide;

N-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N′-[(1R)-2-hydroxy-1-phenylethyl]urea;

N-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N′-(3-ethoxypropyl)urea;

N-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N′-(3-isopropoxypropyl)urea;

N-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N′-(3-isobutoxypropyl)urea;

N-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N′-[3-(methylthio)propyl]urea;

N-benzyl-N′-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N-ethylurea;

N,N-dibenzyl-N′-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N′-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N-methyl-N-(2-phenylethyl)urea;

N′-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methylurea;

4-benzyl-N-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperidine-1-carboxamide;

N-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1-carboxamide;

N-{(3R)-1-[(2-chloro-6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-4-phenylpiperazine-1-carboxamide;

N-[2-(diethylamino)ethyl]-N-methyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N-benzyl-N-ethyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N-benzyl-N-isopropyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N-benzyl-N-butyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N,N-dibenzyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N-benzyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N-(2-phenylethyl)urea;

N 3 ,N 3 -diethyl-N 1 -{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperidine-1,3-dicarboxamide;

N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidine-1-carboxamide;

4-ethyl-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperazine-1-carboxamide;

4-benzyl-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperazine-1-carboxamide;

N-methyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N-propylurea;

N-isobutyl-N-methyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N-methyl-N-(3-methylbutyl)-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N-methyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N-prop-2-ynylurea;

N-ethyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N-propylurea;

N-isopropyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N-propylurea;

N-(sec-butyl)-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N-propylurea;

N,N-dibutyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N-(2-cyanoethyl)-N-cyclopropyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

2-ethyl-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperidine-1-carboxamide;

N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-4-propylpiperidine-1-carboxamide;

N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}azepane-1-carboxamide;

N-ethyl-N-(2-methoxyethyl)-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N-(2-methoxyethyl)-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N-propylurea;

N,N-bis(2-methoxyethyl)-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

1,3,3-trimethyl-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-6-azabicyclo[3.2.1]octane-6-carboxamide;

N-methyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N-(2-phenylethyl)urea;

4-sec-butyl-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperazine-1-carboxamide;

4-(2-ethoxyethyl)-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperazine-1-carboxamide;

4-cyclohexyl-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperazine-1-carboxamide;

N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-4-(2-thien-2-ylethyl)piperazine-1-carboxamide;

N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-4-(2-oxo-2-piperidin-1-ylethyl)piperazine-1-carboxamide;

4-(cyclohexylcarbonyl)-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperazine-1-carboxamide;

N-benzyl-N-(2-hydroxyethyl)-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N-(2-hydroxy-2-phenylethyl)-N-methyl-N′-{1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea;

N-methyl-N′-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-N-(2-pyridin-2-ylethyl)urea;

4-hydroxy-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperidine-1-carboxamide;

N 1 -{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperidine-1,4-dicarboxamide;

N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-1,4-dioxa-8-azaspiro[4.5]decane-8-carboxamide;

2,6-dimethyl-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}morpholine-4-carboxamide;

N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-4-phenylpiperazine-1-carboxamide;

N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-4-pyridin-2-ylpiperazine-1-carboxamide;

4-(2-fluorophenyl)-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperazine-1-carboxamide;

4-(4-fluorophenyl)-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperazine-1-carboxamide;

4-(2-methoxyphenyl)-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperazine-1-carboxamide;

4-methyl-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-1,4-diazepane-1-carboxamide;

ethyl {4-[({(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}amino)carbonyl]piperazin-1-yl}acetate;

N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}-4-(4-nitrophenyl)piperazine-1-carboxamide; and

3-(methoxymethyl)-N-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}piperidine-1-carboxamide.

6. A pharmaceutical composition comprising a compound of claim 1 or a therapeutically acceptable salt thereof, in combination with a therapeutically acceptable carrier.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 030182/0547 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2005
From: HAVIV, FORTUNA; BRADLEY, MICHAEL F.; SAUER, DARYL R.
To: ABBOTT LABORATORIES
Reel/Frame 016189/0708 →